强直性脊柱炎合并帕金森病1例报告并文献复习
Ankylosing Spondylitis Complicated with Parkinson’s Disease: A Case Report and Literature Review
DOI: 10.12677/ACM.2023.134858, PDF,   
作者: 周雪梅, 梁宏达*：青岛大学附属医院风湿免疫科，山东 青岛
关键词: 强直性脊柱炎；帕金森病；阿达木单抗；安健宁；Ankylosing Spondylitis； Parkinson’s Disease； Adamumab； An Jianning
摘要: 目的：报道1例强直性脊柱炎(AS)合并帕金森病(PD)，规律应用阿达木单抗类生物制剂治疗。方法：回顾性描述1例强直性脊柱炎患者的临床资料、实验室及影像学检查并复习相关文献进行分析。结果：1例AS合并PD患者注射安健宁后PD临床症状短时间改善，且无不良反应发生。结论：注射安健宁对短时间改善PD患者临床症状具有一定意义。但仍需进一步临床试验以提供完备的治疗意见。
Abstract: Objective: To report a case of ankylosing spondylitis (AS) complicated with Parkinson’s disease (PD). Methods: The clinical data, laboratory and imaging examination of a patient with ankylosing spon-dylitis were retrospectively described. Results: The clinical symptoms of PD in 1 patient with AS and PD were improved after Anjianning injection, and no adverse reactions occurred. Conclusion: Anjianning injection can improve the clinical symptoms of PD patients in a short time. However, further clinical trials are needed to provide complete treatment advice.
文章引用：周雪梅, 梁宏达. 强直性脊柱炎合并帕金森病1例报告并文献复习[J]. 临床医学进展, 2023, 13(4): 6087-6090. https://doi.org/10.12677/ACM.2023.134858

参考文献

[1] Poddubnyy, D. (2020) Classification vs Diagnostic Criteria: The Challenge of Diagnosing Axial Spondyloarthritis. Rheumatology (Oxford), 59, iv6-iv17. [Google Scholar] [CrossRef] [PubMed]
[2] Reich, S.G. and Savitt, J.M. (2019) Parkinson’s Disease. Medical Clinics of North America, 103, 337-350. [Google Scholar] [CrossRef] [PubMed]
[3] Van der Linden, S., Valkenburg, H.A. and Cats, A. (1984) Evalu-ation of Diagnostic Criteria for Ankylosing Spondylitis. A Proposal for Modification of the New York Criteria. Arthritis & Rheumatology, 27, 361-368. [Google Scholar] [CrossRef] [PubMed]
[4] 陈永平, 商慧芳. 2016中国帕金森病诊断标准解读[J]. 中国实用内科杂志, 2017, 37(2): 124-126.
[5] 陈鹏凯, 阎小萍. 126例强直性脊柱炎患者关节外表现分析[J]. 世界中西医结合杂志, 2014, 9(7): 744-745+792.
[6] 范晓云, 李志军. 强直性脊柱炎的诊断与治疗[J]. 中华全科医学, 2020, 18(8): 1256-1257.
[7] 张缪佳. 强直性脊柱炎的诊断与治疗[J]. 中华全科医学, 2015, 13(12): 1910-1911.
[8] Chen, C.W., Wei, J.C., Gu, J., et al. (2021) Editorial: Advances in Pathogenesis, Etiology, and Thera-pies for Ankylosing Spondylitis. Frontiers in Immunology, 12, Article ID: 822582. [Google Scholar] [CrossRef] [PubMed]
[9] Baraliakos, X., Østergaard, M., Gensler, L.S., et al. (2020) Com-parison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Anky-losing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS). Clinical Drug Investigation, 40, 269-278. [Google Scholar] [CrossRef] [PubMed]
[10] 王医林, 王健, 刘英纯, 等. 强直性脊柱炎患者外周血TNF-α、IL-17、IL-33的表达及与疾病活动程度的相关性研究[J]. 现代生物医学进展, 2017, 17(35): 6934-6937.
[11] 程速远, 赵靖, 胡莹莹, 等. 关于阿达木单抗生物类似药质量相似性评价要点的初步探讨[J]. 中国生物制品学杂志, 2021, 34(5): 626-632.
[12] Kapoor, S., Kaushik, V.V., Jain, R., et al. (2019) Real-Life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: The Adalimumab Biosimilar Patient Registry Data. ACR Open Rheumatology, 1, 480-484. [Google Scholar] [CrossRef] [PubMed]
[13] Mor, D.E., Tsika, E., Mazzulli, J.R., et al. (2017) Dopamine Induces Solu-ble α-Synuclein Oligomers and Nigrostriatal Degeneration. Nature Neuroscience, 20, 1560-1568. [Google Scholar] [CrossRef] [PubMed]
[14] Burbulla, L.F., Song, P., Mazzulli, J.R., et al. (2017) Dopamine Oxidation Mediates Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease. Science, 357, 1255-1261. [Google Scholar] [CrossRef] [PubMed]
[15] Simon, D.K., Tanner, C.M. and Brundin, P. (2020) Parkinson Dis-ease Epidemiology, Pathology, Genetics, and Pathophysiology. Clinics in Geriatric Medicine, 36, 1-12. [Google Scholar] [CrossRef] [PubMed]

为你推荐